FDA.reportPublic FDA data

tafenoquine 150 MG Oral Tablet

RxCUI
2109233
RxNorm name
tafenoquine 150 MG Oral Tablet
Display name
tafenoquine 150 MG Oral Tablet
Full name
tafenoquine 150 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KrintafelTAFENOQUINE SUCCINATEGlaxoSmithKline LLC5cf989d5-36f5-4561-a30b-9fcb9deb6b6a2023-08-02Warnings, Adverse reactionsExact identifier
rxcui: 2109233

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5cf989d5-36f5-4561-a30b-9fcb9deb6b6atafenoquine 150 MG Oral Tablet [PSN] · tafenoquine 150 MG Oral Tablet [SCD] · tafenoquine (as tafenoquine succinate) 150 MG Oral Tablet [SY]312These highlights do not include all the information needed to use KRINTAFEL safely and effectively. See full prescribing information for KRINTAFEL. KRINTAFEL (tafenoquine) tablets, for oral use Initial U.S. Approval: 201820230802